ICFI Stock Analysis: ICF International | NASDAQ
Consulting Services | NASDAQ, USA | Market Cap: 1.404m USD | 12M Return: -12.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.9M
EPS Trend: 38.5%
Qual. Beats: 0
Rev. Trend: -45.7%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ICF International, Inc. (NASDAQ: ICFI) is a management, technology, and policy consulting firm that delivers both advisory and implementation services to government and commercial clients in the U.S. and abroad. The companys work spans a broad set of domains, including strategy and public policy, energy and environmental sustainability, climate resilience, digital transformation (IT modernization, cloud, cybersecurity, and data analytics), health and social programs, international development, disaster management, transportation and infrastructure, and marketing and strategic communications.
Its client base is heavily weighted toward the public sector, encompassing U.S. federal and local government agencies as well as international governments, alongside commercial customers. The firm operates in the government services and consulting sector, where deep domain expertise, security clearances, and long-standing contract relationships are central to the business model. Founded in 1969 and headquartered in Reston, Virginia, ICF was previously known as ICF Consulting Group Holdings, LLC before adopting its current name in 2006, and it trades as a small-cap stock in the Research & Consulting Services sub-industry.
- Federal infrastructure bill drives energy and environment segment growth
- Government shutdown and budget delays create contract revenue timing risk
- Acquisitions and commercial mix expansion reduce federal revenue concentration
| Net Income: 85.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.13 > 1.0 |
| NWC/Revenue: 9.30% < 20% (prev 6.42%; Δ 2.87% < -1%) |
| CFO/TA 0.08 > 3% & CFO 171.8m > Net Income 85.3m |
| Net Debt (761.5m) to EBITDA (196.1m): 3.88 < 3 |
| Current Ratio: 1.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.3m) vs 12m ago -1.43% < -2% |
| Gross Margin: 35.67% > 18% (prev 36.71%; Δ -1.04% > 0.5%) |
| Asset Turnover: 88.31% > 50% (prev 97.01%; Δ -8.70% > 0%) |
| Interest Coverage Ratio: 4.62 > 6 (EBIT TTM 139.6m / Interest Expense TTM 30.2m) |
| A: 0.08 (Total Current Assets 524.4m - Total Current Liabilities 355.0m) / Total Assets 2.05b |
| B: 0.47 (Retained Earnings 974.0m / Total Assets 2.05b) |
| C: 0.07 (EBIT TTM 139.6m / Avg Total Assets 2.06b) |
| D: 1.01 (Book Value of Equity 1.03b / Total Liabilities 1.02b) |
| Altman-Z'' = 3.60 = AA |
| DSRI: 1.07 (Receivables 451.3m/465.5m, Revenue 1.82b/2.01b) |
| GMI: 1.03 (GM 36.71% / 35.67%) |
| AQI: 1.00 (AQ_t 0.67 / AQ_t-1 0.67) |
| SGI: 0.91 (Revenue 1.82b / 2.01b) |
| TATA: -0.04 (NI 85.3m - CFO 171.8m) / TA 2.05b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of July 15, 2026, the stock is trading at USD 76.35 with a total of 312,818 shares traded. Over the past week, the price has changed by -0.82%, over one month by +5.82%, over three months by +8.94% and over the past year by -12.40%.
Current recommended Stop Loss: 72.00 (which is 5.7% or 1.4 ATR below the current price).
ICF International has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ICFI.
- StrongBuy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 105.3 | 37.9% |
P/E Trailing = 16.7473
P/E Forward = 10.5932
P/S = 0.7702
P/B = 1.3135
P/EG = 1.8146
Revenue TTM = 1.82b USD
EBIT TTM = 139.6m USD
EBITDA TTM = 196.1m USD
Long Term Debt = 439.2m USD (from longTermDebt, last quarter)
Short Term Debt = 19.7m USD (from shortTermDebt, last quarter)
Debt = 765.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 163.1m
Net Debt = 761.5m USD (calculated: Debt 765.4m - CCE 3.88m)
Enterprise Value = 2.17b USD (1.40b + Debt 765.4m - CCE 3.88m)
Interest Coverage Ratio = 4.62 (Ebit TTM 139.6m / Interest Expense TTM 30.2m)
EV/FCF = 14.37x (Enterprise Value 2.17b / FCF TTM 150.7m)
FCF Yield = 6.96% (FCF TTM 150.7m / Enterprise Value 2.17b)
FCF Margin = 8.27% (FCF TTM 150.7m / Revenue TTM 1.82b)
Net Margin = 4.68% (Net Income TTM 85.3m / Revenue TTM 1.82b)
Gross Margin = 35.67% ((Revenue TTM 1.82b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Gross Margin QoQ = 35.13% (prev 32.43%)
Tobins Q-Ratio = 1.05 (Enterprise Value 2.17b / Total Assets 2.05b)
Interest Expense / Debt = 3.95% (Interest Expense 30.2m / Debt 765.4m)
Taxrate = 22.05% (24.1m / 109.4m)
NOPAT = 108.8m (EBIT 139.6m * (1 - 22.05%))
Current Ratio = 1.48 (Total Current Assets 524.4m / Total Current Liabilities 355.0m)
Debt / Equity = 0.74 (Debt 765.4m / totalStockholderEquity, last quarter 1.03b)
Debt / EBITDA = 3.88 (Net Debt 761.5m / EBITDA 196.1m)
Debt / FCF = 5.05 (Net Debt 761.5m / FCF TTM 150.7m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.13% (Net Income 85.3m / Total Assets 2.05b)
RoE = 8.35% (Net Income TTM 85.3m / Total Stockholder Equity 1.02b)
RoCE = 9.56% (EBIT 139.6m / Capital Employed (Equity 1.02b + L.T.Debt 439.2m))
RoIC = 6.35% (NOPAT 108.8m / Invested Capital 1.71b)
WACC = 5.95% (E(1.40b)/V(2.17b) * Re(7.51%) + D(765.4m)/V(2.17b) * Rd(3.95%) * (1-Tc(0.22)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.16 | Cagr: -1.60%
[DCF] Terminal Value 77.97% ; FCFF base≈142.0m ; Y1≈162.8m ; Y5≈239.5m
[DCF] Fair Price = 157.0 (EV 3.60b - Net Debt 761.5m = Equity 2.84b / Shares 18.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 38.47 | EPS CAGR: 3.25% | SUE: -0.31 | # QB: 0
Revenue Correlation: -45.73 | Revenue CAGR: -1.53% | SUE: -0.92 | # QB: -1
EPS current Quarter (2026-06-30): EPS=1.65 | Chg30d=-3.18% | Revisions=-57% | Analysts=5
EPS next Quarter (2026-09-30): EPS=1.99 | Chg30d=+2.81% | Revisions=+29% | Analysts=5
EPS current Year (2026-12-31): EPS=7.02 | Chg30d=-0.06% | Revisions=+38% | GrowthEPS=+3.7% | GrowthRev=+1.8%
EPS next Year (2027-12-31): EPS=7.68 | Chg30d=+0.31% | Revisions=+29% | GrowthEPS=+9.4% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: +15% (up=10, down=7)